In this final installment her interview with Pharmaceutical Commerce, Laura Blair, chief commercial officer at ConnectiveRx, shifts her focus to the long-term trajectory of the specialty patient journey. Having previously discussed the mechanics of
The conversation centers on a critical industry challenge: ensuring that patients don’t just start their specialized therapies, but successfully navigate the complex path from initial prescription through to consistent, long-term adherence. Blair emphasizes that the key to modernizing these models lies in simplification and strategic timing.
According to Blair, the industry must prioritize “cleaner” digital tools that reduce friction for both providers and patients. By integrating support resources directly into electronic health record systems and existing clinical workflows, manufacturers can reach stakeholders at the exact moment of prescribing. This “at-the-point-of-care” approach is designed to provide immediate diagnostic and enrollment support, effectively closing the gap between the doctor’s office and the patient’s first dose.
Access the first and second parts of her interview with PC: